PC
CTOR

Periscope Capital’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History

Periscope Capital’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-358,788
Closed -$3.93M – 436
2023
Q4 		$3.93M Buy
358,788
+17,538
+5% +$192K 0.66% 46
2023
Q3 		$3.68M Buy
341,250
+7,623
+2% +$82.1K 0.42% 84
2023
Q2 		$3.51M Buy
333,627
+9,127
+3% +$96.1K 0.27% 131
2023
Q1 		$3.36M Buy
+324,500
New +$3.36M 0.16% 204